Replies to post #937 on Idenix Pharmaceuticals (IDIX)

[go seek]

IND for IDX-899 was filed (as expected)

* In April, an electronic investigational new drug (eIND) application for IDX899, a non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidate for the treatment of HIV, was filed to support a phase I study in healthy volunteers.

[go seek]

$10 million of which was received in April 2007.

that's the 2nd qtr... they gonna get another $10 in the 2nd qtr?